US Stock MarketDetailed Quotes

ABMT ADVANCED BIOMEDICAL TECHNOLOGIES

Watchlist

0.000600
0.0000000.00%

15min DelayClose Apr 1 16:00 ET

42.13KMarket Cap-60P/E (TTM)

ADVANCED BIOMEDICAL TECHNOLOGIES Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Jul 31, 2021

(Q2)Apr 30, 2021

(Q1)Jan 31, 2021

(FY)Oct 31, 2020

(Q4)Oct 31, 2020

(Q3)Jul 31, 2020

(Q2)Apr 30, 2020

(Q1)Jan 31, 2020

(FY)Oct 31, 2019

(Q4)Oct 31, 2019

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-179.86%-80.97K

5.02%-147.26K

-892.71%-514.82K

187.09%646.66K

490.76%752.17K

183.10%101.39K

32.08%-155.04K

74.04%-51.86K

10.80%-742.53K

16.58%-192.49K

Net income from continuing operations

3.17%-198.71K

9.81%-189.09K

-169.71%-172.04K

29.18%-672K

21.96%-193.33K

3.59%-205.23K

11.04%-209.65K

74.74%-63.79K

0.47%-948.82K

19.07%-247.74K

Operating gains losses

1,100.00%24

----

--3.95K

--2

----

Depreciation and amortization

137.31%6.58K

-15.55%12.41K

-1.37%15.74K

185.42%60.37K

863.22%47.35K

-383.41%-17.63K

193.06%14.69K

219.08%15.95K

29.79%21.15K

-1.32%4.92K

Other non cash items

-86.68%4.87K

-101.31%-59

84.64%8.65K

144.49%68.35K

22.62%22.58K

1,047.07%36.58K

40.54%4.51K

48.86%4.69K

-58.00%27.96K

-66.68%18.41K

Change In working capital

-61.17%110K

-13.80%24.96K

-4,114.90%-367.16K

654.53%1.19M

2,664.52%882.49K

247.70%283.26K

3,661.50%28.96K

-119.53%-8.71K

313.22%157.18K

110.94%31.92K

-Change in receivables

223.73%6.36K

-87.21%2.91K

-196.05%-27.68K

233.41%23.67K

1,954.22%8.34K

154.66%1.96K

946.98%22.72K

15.15%-9.35K

-5.24%-17.75K

97.04%-450

-Change in inventory

-97.55%-29.49K

-129.81%-37.49K

-213.43%-17.79K

52.22%-31.28K

46.53%-15.73K

32.32%-14.93K

-16.52%-16.31K

--15.69K

---65.47K

---29.42K

-Change in payables and accrued expense

-55.57%130.96K

232.99%57.42K

-2,027.91%-323.4K

393.83%1.19M

1,341.79%888.34K

175.45%294.79K

9.58%17.24K

-127.32%-15.2K

337.15%240K

103.27%61.61K

-Change in other working capital

51.32%2.18K

-59.98%2.12K

1,020.92%1.72K

1,987.13%8.43K

784.97%1.53K

1,354.55%1.44K

--5.31K

--153

--404

--173

Cash from discontinued investing activities

Operating cash flow

-179.86%-80.97K

5.02%-147.26K

-892.71%-514.82K

187.09%646.66K

490.76%752.17K

183.10%101.39K

32.08%-155.04K

74.04%-51.86K

10.80%-742.53K

16.58%-192.49K

Investing cash flow

Cash flow from continuing investing activities

-37.41%-1.95K

-12.82%-31.3K

-3,365.14%-18.19K

-65.40%-30.71K

-106.56%-1.01K

69.50%-1.42K

-542.10%-27.75K

97.90%-525

71.17%-18.57K

210.29%15.46K

Net PPE purchase and sale

-37.41%-1.95K

-12.82%-31.3K

-3,365.14%-18.19K

-65.40%-30.71K

-106.56%-1.01K

69.50%-1.42K

-542.10%-27.75K

97.90%-525

71.17%-18.57K

210.29%15.46K

Cash from discontinued investing activities

Investing cash flow

-37.41%-1.95K

-12.82%-31.3K

-3,365.14%-18.19K

-65.40%-30.71K

-106.56%-1.01K

69.50%-1.42K

-542.10%-27.75K

97.90%-525

71.17%-18.57K

210.29%15.46K

Financing cash flow

Cash flow from continuing financing activities

186.34%83.14K

-5.38%175.49K

511.50%335.14K

-156.30%-427.82K

-432.98%-571.8K

-176.54%-96.29K

-18.55%185.46K

-76.64%54.81K

-15.22%759.84K

-27.04%171.72K

Net issuance payments of debt

67.69%-3.55K

12.24%-9.52K

-14.53%-12.29K

---44.13K

---11.56K

---10.99K

---10.85K

---10.73K

--0

Cash dividends paid

--0

Net other financing activities

203.69%87.51K

-5.95%185.66K

420.66%347.99K

-149.96%-379.64K

-425.81%-559.49K

-167.09%-84.4K

-13.30%197.41K

-71.51%66.84K

-15.22%759.84K

-27.04%171.72K

Cash from discontinued financing activities

Financing cash flow

186.34%83.14K

-5.38%175.49K

511.50%335.14K

-156.30%-427.82K

-432.98%-571.8K

-176.54%-96.29K

-18.55%185.46K

-76.64%54.81K

-15.22%759.84K

-27.04%171.72K

Net cash flow

Beginning cash position

-43.53%6.01K

5.01%8.49K

3,506.29%201.66K

-18.48%5.59K

33.07%14.47K

-10.44%10.64K

-52.28%8.09K

-18.48%5.59K

-8.08%6.86K

-31.83%10.88K

Current changes in cash

-94.04%219

-214.71%-3.07K

-8,276.61%-197.87K

15,114.60%188.13K

3,479.72%179.36K

529.09%3.67K

154.63%2.68K

-75.34%2.42K

-129.49%-1.25K

43.55%-5.31K

Effect of exchange rate changes

369.57%756

575.00%589

6,252.70%4.7K

53,026.67%7.94K

35,481.82%7.83K

209.52%161

23.93%-124

-72.89%74

73.68%-15

-92.81%22

End cash Position

-51.75%6.98K

-43.53%6.01K

5.01%8.49K

3,506.29%201.66K

33.07%14.47K

-10.44%10.64K

-52.28%8.09K

-18.48%5.59K

Free cash flow

-182.95%-82.92K

2.31%-178.56K

-917.48%-533.01K

180.93%615.95K

524.31%751.16K

178.92%99.96K

21.42%-182.78K

76.70%-52.39K

15.13%-761.1K

27.67%-177.03K

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Jul 31, 2021	(Q2)Apr 30, 2021	(Q1)Jan 31, 2021	(FY)Oct 31, 2020	(Q4)Oct 31, 2020	(Q3)Jul 31, 2020	(Q2)Apr 30, 2020	(Q1)Jan 31, 2020	(FY)Oct 31, 2019	(Q4)Oct 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-179.86%-80.97K	5.02%-147.26K	-892.71%-514.82K	187.09%646.66K	490.76%752.17K	183.10%101.39K	32.08%-155.04K	74.04%-51.86K	10.80%-742.53K	16.58%-192.49K
Net income from continuing operations	3.17%-198.71K	9.81%-189.09K	-169.71%-172.04K	29.18%-672K	21.96%-193.33K	3.59%-205.23K	11.04%-209.65K	74.74%-63.79K	0.47%-948.82K	19.07%-247.74K
Operating gains losses	1,100.00%24	----	----	--3.95K	--3.95K	--2	----	----	----	----
Depreciation and amortization	137.31%6.58K	-15.55%12.41K	-1.37%15.74K	185.42%60.37K	863.22%47.35K	-383.41%-17.63K	193.06%14.69K	219.08%15.95K	29.79%21.15K	-1.32%4.92K
Other non cash items	-86.68%4.87K	-101.31%-59	84.64%8.65K	144.49%68.35K	22.62%22.58K	1,047.07%36.58K	40.54%4.51K	48.86%4.69K	-58.00%27.96K	-66.68%18.41K
Change In working capital	-61.17%110K	-13.80%24.96K	-4,114.90%-367.16K	654.53%1.19M	2,664.52%882.49K	247.70%283.26K	3,661.50%28.96K	-119.53%-8.71K	313.22%157.18K	110.94%31.92K
-Change in receivables	223.73%6.36K	-87.21%2.91K	-196.05%-27.68K	233.41%23.67K	1,954.22%8.34K	154.66%1.96K	946.98%22.72K	15.15%-9.35K	-5.24%-17.75K	97.04%-450
-Change in inventory	-97.55%-29.49K	-129.81%-37.49K	-213.43%-17.79K	52.22%-31.28K	46.53%-15.73K	32.32%-14.93K	-16.52%-16.31K	--15.69K	---65.47K	---29.42K
-Change in payables and accrued expense	-55.57%130.96K	232.99%57.42K	-2,027.91%-323.4K	393.83%1.19M	1,341.79%888.34K	175.45%294.79K	9.58%17.24K	-127.32%-15.2K	337.15%240K	103.27%61.61K
-Change in other working capital	51.32%2.18K	-59.98%2.12K	1,020.92%1.72K	1,987.13%8.43K	784.97%1.53K	1,354.55%1.44K	--5.31K	--153	--404	--173
Cash from discontinued investing activities
Operating cash flow	-179.86%-80.97K	5.02%-147.26K	-892.71%-514.82K	187.09%646.66K	490.76%752.17K	183.10%101.39K	32.08%-155.04K	74.04%-51.86K	10.80%-742.53K	16.58%-192.49K
Investing cash flow
Cash flow from continuing investing activities	-37.41%-1.95K	-12.82%-31.3K	-3,365.14%-18.19K	-65.40%-30.71K	-106.56%-1.01K	69.50%-1.42K	-542.10%-27.75K	97.90%-525	71.17%-18.57K	210.29%15.46K
Net PPE purchase and sale	-37.41%-1.95K	-12.82%-31.3K	-3,365.14%-18.19K	-65.40%-30.71K	-106.56%-1.01K	69.50%-1.42K	-542.10%-27.75K	97.90%-525	71.17%-18.57K	210.29%15.46K
Cash from discontinued investing activities
Investing cash flow	-37.41%-1.95K	-12.82%-31.3K	-3,365.14%-18.19K	-65.40%-30.71K	-106.56%-1.01K	69.50%-1.42K	-542.10%-27.75K	97.90%-525	71.17%-18.57K	210.29%15.46K
Financing cash flow
Cash flow from continuing financing activities	186.34%83.14K	-5.38%175.49K	511.50%335.14K	-156.30%-427.82K	-432.98%-571.8K	-176.54%-96.29K	-18.55%185.46K	-76.64%54.81K	-15.22%759.84K	-27.04%171.72K
Net issuance payments of debt	67.69%-3.55K	12.24%-9.52K	-14.53%-12.29K	---44.13K	---11.56K	---10.99K	---10.85K	---10.73K	--0	--0
Cash dividends paid	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Net other financing activities	203.69%87.51K	-5.95%185.66K	420.66%347.99K	-149.96%-379.64K	-425.81%-559.49K	-167.09%-84.4K	-13.30%197.41K	-71.51%66.84K	-15.22%759.84K	-27.04%171.72K
Cash from discontinued financing activities
Financing cash flow	186.34%83.14K	-5.38%175.49K	511.50%335.14K	-156.30%-427.82K	-432.98%-571.8K	-176.54%-96.29K	-18.55%185.46K	-76.64%54.81K	-15.22%759.84K	-27.04%171.72K
Net cash flow
Beginning cash position	-43.53%6.01K	5.01%8.49K	3,506.29%201.66K	-18.48%5.59K	33.07%14.47K	-10.44%10.64K	-52.28%8.09K	-18.48%5.59K	-8.08%6.86K	-31.83%10.88K
Current changes in cash	-94.04%219	-214.71%-3.07K	-8,276.61%-197.87K	15,114.60%188.13K	3,479.72%179.36K	529.09%3.67K	154.63%2.68K	-75.34%2.42K	-129.49%-1.25K	43.55%-5.31K
Effect of exchange rate changes	369.57%756	575.00%589	6,252.70%4.7K	53,026.67%7.94K	35,481.82%7.83K	209.52%161	23.93%-124	-72.89%74	73.68%-15	-92.81%22
End cash Position	-51.75%6.98K	-43.53%6.01K	5.01%8.49K	3,506.29%201.66K	3,506.29%201.66K	33.07%14.47K	-10.44%10.64K	-52.28%8.09K	-18.48%5.59K	-18.48%5.59K
Free cash flow	-182.95%-82.92K	2.31%-178.56K	-917.48%-533.01K	180.93%615.95K	524.31%751.16K	178.92%99.96K	21.42%-182.78K	76.70%-52.39K	15.13%-761.1K	27.67%-177.03K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall